Novo Nordisk (NOVOB DC) introduces Ozempic pill; available in the US Q2 2026; expects FDA decision on supplemental drug application for Ozempic tablets 25 mg for use in adults with Type 2 Diabetes by end of 2026

Novo Nordisk's introduction of an Ozempic pill signals a strategic expansion of its product offerings, which could enhance its competitive edge in the diabetes market.

Newsquawk StaffPublished 4 Feb 2026, 17:22 UTCOn the live feed at 17:02 UTC — 3 more headlines followed before this page went public

Newsquawk headlinesUTC

17:10

Stellantis (STLAM IM/STLAP FP) faces Peugeot model delays from battery plant snags, Bloomberg reports

17:08

Newsquawk Daily US Earnings Estimates - 5th February 2026: CI, BMY, AMZN

17:02

Novo Nordisk (NOVOB DC) introduces Ozempic pill; available in the US Q2 2026; expects FDA decision on supplemental drug application for Ozempic tablets 25 mg for use in adults with Type 2 Diabetes by end of 2026

17:01

US, EU, and Japan will sign a MoU within 30 days to strengthen critical minerals supply chains

17:00

USTR says US and Mexico to explore border-adjusted price floors for critical minerals imports over next 60 days; US and Mexico consulting on how price floors could be included in plurilateral agreement on trade in critical minerals

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Context

The expected FDA decision by the end of 2026 could impact market sentiment around the stock, depending on the perceived likelihood of approval and the potential for increased patient access. This move aligns with the ongoing trend towards oral diabetes medications, which may have broader implications for pricing and competition within the sector.

All markets · last 90 days

Recent headlines that moved markets

METALS/1 Sep · 08:06

Two oil supertankers were reportedly hit by projectiles in the Strait of Hormuz, reports citing Marisks suggest (details light)

Spot Gold, after we published−1.0%

Further upside seen in energy, downside in equities and fixed and fresh USD strength following this. - Spot gold slipped to USD 4390/oz before dipping lower.

FX/28 Aug · 14:00

Fed Chair Warsh says Fed has more work to do unless confident underlying inflation is moving towards 2% objective

+0.5%DXY

ENERGY/27 Aug · 17:46

The Trump administration has repeatedly told mediators it has no interest in going back to the terms of the MoU it reached with Iran in June, reports WSJ citing sources

+1.4%Brent crude

EQUITIES/26 Aug · 12:56

States and Meta (META) and agree to settle claims that platforms harmed children, according to a court filing; Meta agrees to pay a maximum of USD 16.68bln to states as part of deal

+2.6%market

ENERGY/25 Aug · 19:26

A ceasefire between the US and Iran has been agreed upon, it includes free navigation in the Strait of Hormuz and will be announced in the coming days, reports Ria citing Pakistani and Iranian sources

−2.4%Brent crude

FX/2 Sep · 13:45

BoC holds rates as expected as 2.25%

−0.3%USD/CAD

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.